| Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1 |
Globe Newswire |
05/04 |
08:00 |
| CHUCK E. CHEESE ANNOUNCES LARGEST SUMMER HIRING PUSH AND NEWSWEEK RECOGNITION |
Globe Newswire |
05/04 |
08:00 |
| Bascom Palmer Eye Institute Presents Four Posters on Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2026, Advancing the Clinical Case for Provectus’s VisiRose Subsidiary and Rose Bengal Sodium in Infectious Keratitis |
Globe Newswire |
05/04 |
08:00 |
| Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology |
Globe Newswire |
05/04 |
08:00 |
| Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth |
Globe Newswire |
05/04 |
08:00 |
| ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 |
Globe Newswire |
05/04 |
08:00 |
| Terra Innovatum Expands U.S. Presence with Pittsburgh, Pa. Headquarters and Leadership Appointments to Advance SOLO™ Licensing Readiness and FOAK Deployment |
Globe Newswire |
05/04 |
08:00 |
| ASML reports transactions under its current share buyback program |
Globe Newswire |
05/04 |
08:00 |
| Allied Gaming & Entertainment Announces Proposed Rebranding to “AI & FutureTech Alliance Limited (AIFA)” and Plans for Hainan Silicon Photonics AI Supercomputing Center, Supported by Convertible Notes Financing plan to Build a Global Optical Compute Network Platform |
Globe Newswire |
05/04 |
08:00 |
| Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting |
Globe Newswire |
05/04 |
08:00 |
| Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer |
Globe Newswire |
05/04 |
08:00 |
| 4DMT to Participate in Upcoming Investor Conferences |
Globe Newswire |
05/04 |
08:00 |
| Blink Charging to Host First Quarter Conference Call on Monday, May 11, 2026 |
Globe Newswire |
05/04 |
08:00 |
| News Release in accordance with Canadian National Instrument 62-103 |
Globe Newswire |
05/04 |
08:00 |
| Applied Digital Announces $300 Million Senior Secured Bridge Facility |
Globe Newswire |
05/04 |
08:00 |
| Dime Launches Equipment & Franchise Finance Group |
Globe Newswire |
05/04 |
08:00 |
| U.S. Department of Energy–Funded Study Supports General Fusion’s Fuel Cycle Design |
Globe Newswire |
05/04 |
08:00 |
| Apollo Closes Accord Fund VII at $1.9 Billion |
Globe Newswire |
05/04 |
08:00 |
| Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis |
Globe Newswire |
05/04 |
08:00 |
| Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial |
Globe Newswire |
05/04 |
08:00 |
| Off The Hook Yachts to Announce 2026 First Quarter Financial and Operating Results on Thursday, May 14, 2026 |
Globe Newswire |
05/04 |
08:00 |
| Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton |
Globe Newswire |
05/04 |
08:00 |
| Zyter Launches Praxis, an AI Engine for Executing End-to-end Enterprise Workflows |
Globe Newswire |
05/04 |
08:00 |
| American Fusion Inc. (OTC: AMFN) Confirms Reduction in Authorized Common Shares and Provides Financing Update |
Globe Newswire |
05/04 |
08:00 |
| Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society |
Globe Newswire |
05/04 |
08:00 |
